University of Tennessee cancels public COVID-19 vaccination clinic following FDA, CDC recommendation

Recipients signing up for the vaccination clinic will receive the Johnson and Johnson COVID-19 vaccine.
Published: Apr. 12, 2021 at 6:58 PM EDT|Updated: Apr. 13, 2021 at 10:37 AM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

KNOXVILLE, Tenn. (WVLT) -The University of Tennessee has canceled its COVID-19 vaccination event Tuesday morning after the FDA and CDC recommended a pause in the Johnson & Johnson vaccine.

The event was set to solely distribute the Johnson & Johnson vaccine.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.

Staff members were seen turning people away from the vaccine event Tuesday morning shortly after the announcement.

UT officials told WVLT they are in contact with the Tennessee Department of Health to gather more information.

The university was set to host another vaccine event on Friday, April 16 to distribute the Johnson & Johnson vaccine. University officials said they will now use the Moderna vaccine for that clinic.

Anyone with an appointment this week, April 13–16, for Johnson & Johnson’s Janssen vaccine at Tuesday’s public clinic or through the Student Health Center will be provided information on rescheduling to receive the Moderna vaccine on Friday, April 16. People already signed up for Friday’s public clinic can keep their appointments.

To schedule an appointment, go to

Pellissippi State announced they have also halted their vaccination clinic due to the CDC recommendation.

Copyright 2021 WVLT. All rights reserved